ScholarLens Back to search
2012•Journal of Cancer Research and Clinical OncologyOpen access

Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels

Aslı Kısım, Harika Atmaca, Burcu Çakar, Bülent Karabulut, Canfeza Sezgin, Selim Uzunoğlu, Rüçhan Uslu, Burçak Karaca

Open full text 24 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 24 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Apoptosis, Tumor necrosis factor alpha, DNA fragmentation, Programmed cell death, Cancer research, Cancer cell, Cytotoxicity, Breast cancer

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels — Research Paper | ScholarLens